Babatunde Olanrewaju Motayo1, Adedayo Omotayo Faneye2, Usen Asuquo Udo3, Babatunde Adebiyi Olusola2, Isreal Ezeani4, Joseph Iruobe Ogiogwa5. 1. Microbiology Unit, Pathology department, Federal Medical Centre, Abeokuta ; Department of Virology, College of Medicine, University of Ibadan. 2. Department of Virology, College of Medicine, University of Ibadan. 3. Hematology and Blood Transfusion Unit, Pathology department, Federal Medical Centre, Abeokuta. 4. Microbiology Unit, Pathology department, Federal Medical Centre, Abeokuta ; Hematology and Blood Transfusion Unit, Pathology department, Federal Medical Centre, Abeokuta. 5. Microbiology Unit, Pathology department, Federal Medical Centre, Abeokuta.
Abstract
BACKGROUND: Transfusion transmissible infections, such as HIV, HBV, HCV and syphilis are on the rise and pose a threat to blood safety. OBJECTIVE: To determine prevalence and demographic profiles of TTI's among first time blood donors in Abeokuta, Nigeria. METHODS: The study was conducted between February to November 2013; 130 first time blood donors were tested for the presence of HIV, HBsAg, HCV antibodies and Treponema palidium antibodies using EIA based rapid immunochromatographic kits. Data analysis was done using SPSS with a level of significance of p<0.05. RESULTS: Prevalence rates to HIV, HBsAg, HCV antibody, were 6.2% (n=8), 10% (n=13) and 1.5% (n=2), there was 0% prevalence to Treponema palidium antibodies. Group specific prevalence rates revealed that educational status was associated with HBsAg positivity (p = 0.028), donors with a history of previous blood transfusion was also statistically associated with HIV sero-reactivity (p = 0.013). CONCLUSIONS: High levels of HBsAg and HIV were observed, there is need to revise the donor testing algorithm in Nigeria in line with the prevalence of TTI's. We also advocate that a National surveillance system for TTI's be established through our National blood transfusion service (NBTS) program, a second serological test is also suggested to reduce the risk of occult HBV infection in Nigeria.
BACKGROUND: Transfusion transmissible infections, such as HIV, HBV, HCV and syphilis are on the rise and pose a threat to blood safety. OBJECTIVE: To determine prevalence and demographic profiles of TTI's among first time blood donors in Abeokuta, Nigeria. METHODS: The study was conducted between February to November 2013; 130 first time blood donors were tested for the presence of HIV, HBsAg, HCV antibodies and Treponema palidium antibodies using EIA based rapid immunochromatographic kits. Data analysis was done using SPSS with a level of significance of p<0.05. RESULTS: Prevalence rates to HIV, HBsAg, HCV antibody, were 6.2% (n=8), 10% (n=13) and 1.5% (n=2), there was 0% prevalence to Treponema palidium antibodies. Group specific prevalence rates revealed that educational status was associated with HBsAg positivity (p = 0.028), donors with a history of previous blood transfusion was also statistically associated with HIV sero-reactivity (p = 0.013). CONCLUSIONS: High levels of HBsAg and HIV were observed, there is need to revise the donor testing algorithm in Nigeria in line with the prevalence of TTI's. We also advocate that a National surveillance system for TTI's be established through our National blood transfusion service (NBTS) program, a second serological test is also suggested to reduce the risk of occult HBV infection in Nigeria.
Authors: Bolni Marius Nagalo; Cyrille Bisseye; Mahamoudou Sanou; Kisito Kienou; Yacouba K Nebié; Alice Kiba; Honorine Dahourou; Siaka Ouattara; Jean Baptiste Nikiema; Rémy Moret; Jean Didier Zongo; Jacques Simpore Journal: Trop Med Int Health Date: 2011-10-12 Impact factor: 2.622
Authors: Samuel O Ola; Jesse A Otegbayo; Georgina N Odaibo; David O Olaleye; Itunu O Olubuyide; Christopher B Summerton; Elijah A Bamgboye Journal: J Infect Dev Ctries Date: 2009-07-01 Impact factor: 0.968
Authors: Yasser Ahmed Ghaleb; Ali Abdullah Al-Somainy; Mohammed Abdullah Alamad; Abdulwahed Abduljabbar Al Serouri; Yousef S Khader Journal: Inquiry Date: 2019 Jan-Dec Impact factor: 1.730